1MJ8 image
Deposition Date 2002-08-27
Release Date 2003-09-23
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1MJ8
Keywords:
Title:
High Resolution Crystal Structure Of The Fab Fragment of The Esterolytic Antibody MS6-126
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.75 Å
R-Value Free:
0.22
R-Value Work:
0.15
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:IMMUNOGLOBULIN MS6-126
Chain IDs:B (auth: H)
Chain Length:230
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:IMMUNOGLOBULIN MS6-126
Chain IDs:A (auth: L)
Chain Length:219
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity
J.Mol.Biol. 332 423 435 (2003)
PMID: 12948492 DOI: 10.1016/S0022-2836(03)00902-1

Abstact

The crystal structures of four related Fab fragments of a family of catalytic antibodies displaying differential levels of esterase activity have been solved in the presence and in the absence of the transition-state analogue (TSA) that was used to elicit the immune response. The electron density maps show that the TSA conformation is essentially identical, with limited changes on hapten binding. Interactions with the TSA explain the specificity for the D rather than the L-isomer of the substrate. Differences in the residues in the hapten-binding pocket, which increase hydrophobicity, appear to correlate with an increase in the affinity of the antibodies for their substrate. Analysis of the structures at the active site reveals a network of conserved hydrogen bond contacts between the TSA and the antibodies, and points to a critical role of two conserved residues, HisL91 and LysH95, in catalysis. However, these two key residues are set into very different contexts in their respective structures, with an apparent direct correlation between the catalytic power of the antibodies and the complexity of their interactions with the rest of the protein. This suggests that the catalytic efficiency may be controlled by contacts arising from a second sphere of residues at the periphery of the active site.

Legend

Protein

Chemical

Disease

Primary Citation of related structures